gonadotropin releasing hormone (GnRH)

DRUG5 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Massachusetts General Hospital, Region Örebro County

Conditions

GnRH DeficiencyGonadal DisorderHypogonadismHypogonadotropic HypogonadismIdiopathic Hypogonadotropic HypogonadismKallmann SyndromePuberty, Precocious

Phase 1

Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

CompletedNCT00392756

Massachusetts General HospitalGnRH Deficiency, Hypogonadotropic Hypogonadism, Kallmann Syndrome

Start: 1989-04-30End: 2019-05-16Updated: 2022-07-11

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

CompletedNCT00493961

Massachusetts General HospitalGnRH Deficiency, Idiopathic Hypogonadotropic Hypogonadism, Kallmann Syndrome

Start: 1999-01-31End: 2009-11-17Updated: 2022-07-01

Phase 2

Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism

TerminatedNCT00064987

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Hypogonadism, Kallmann Syndrome

Start: 2001-04-30End: 2012-10-31Updated: 2017-07-07

Unknown Phase

Investigating the Regulation of Reproductive Hormones in Adult Men

CompletedNCT00392457

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Gonadal Disorder, Hypogonadism, Kallmann Syndrome

Start: 1995-07-31End: 2007-02-28Target: 175Updated: 2015-02-16

Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty

CompletedNCT02431416

Region Örebro CountyPuberty, Precocious

Start: 2015-05-31End: 2018-09-30Updated: 2019-04-01

Related Papers

Reversal of idiopathic hypogonadotropic hypogonadism.

2007-08-01235 citations